These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 13619015)

  • 1. Fibrinolytic (plasmin) therapy of experimental coronary thrombi with alteration of the evolution of myocardial infarction.
    RUEGSEGGER P; NYDICK I; HUTTER RC; FREIMAN AH; BANG NU; CLIFFTON EE; LADUE JS
    Circulation; 1959 Jan; 19(1):7-13. PubMed ID: 13619015
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of fibrinolytic (plasmin) therapy on the physiopathology of myocardial infarction.
    RUEGSEGGER P; NYDICK I; ABARQUEZ R; REICHEL F; CLIFFTON EE; LADUE JS
    Am J Cardiol; 1960 Aug; 6():519-24. PubMed ID: 14440043
    [No Abstract]   [Full Text] [Related]  

  • 3. In vivo fibrinolytic activity and pharmacology of various plasmin (fibrinolysin) preparations.
    BACK N; AMBRUS JL; GOLDSTEIN S; HARRISSON JW
    Circ Res; 1956 Jul; 4(4):440-3. PubMed ID: 13330188
    [No Abstract]   [Full Text] [Related]  

  • 4. IMPROVED LONG-TERM SURVIVAL FOLLOWING MYOCARDIAL INFARCTION WITH FIBRINOLYTIC THERAPY.
    BOYLES PW
    Angiology; 1965 Jun; 16():346-50. PubMed ID: 14294430
    [No Abstract]   [Full Text] [Related]  

  • 5. Plasmin-antiplasmin complex as a reservoir of fibrinolytic enzyme.
    AMBRUS CM; MARKUS G
    Am J Physiol; 1960 Sep; 199():491-4. PubMed ID: 13682944
    [No Abstract]   [Full Text] [Related]  

  • 6. [Estimation of the length of coronary thrombi and prediction of the result of coronary thrombolytic therapy based on the angiographic findings].
    Mochida Y
    J Cardiol; 1996 Nov; 28(5):249-55. PubMed ID: 8953398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [POSSIBILITIES AND LIMITATIONS OF COMBINED FIBRINOLYTIC-ANTICOAGULANT THERAPY OF MYOCARDIAL INFARCT].
    VAN DE LOO J
    Med Klin; 1963 Sep; 58():1527-9. PubMed ID: 14050311
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of coronary and myocardial morphologic findings in patients with and without thrombolytic therapy during fatal first acute myocardial infarction. The TIMI Investigators.
    Gertz SD; Kragel AH; Kalan JM; Braunwald E; Roberts WC
    Am J Cardiol; 1990 Oct; 66(12):904-9. PubMed ID: 2121015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of patients with acute coronary insufficiency with thrombolytic preparations (fibrinolysin and thrombolytin)].
    Khalfen ESh; Orlova NP
    Ter Arkh; 1968 Dec; 40(12):48-52. PubMed ID: 4247402
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies of inhibition of the plasmin-plasminogen fibrinolytic enzyme system in patients with myocardial infarction.
    SANDBERG H; TSITOURIS G; DELEON AC; BELLET S
    Am J Cardiol; 1960 May; 5():666-73. PubMed ID: 14441369
    [No Abstract]   [Full Text] [Related]  

  • 11. [Planar myocardial scintigraphy with technetium-99m-sestamibi in acute myocardial infarct treated with thrombolytic therapy].
    Zammarchi A; Pitscheider W; Mautone A; Oberhollenzer R; Lintner W; Erlicher A; Crepaz R; Osele L; Braito E
    G Ital Cardiol; 1995 Aug; 25(8):1011-9. PubMed ID: 7498619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular basis of fibrinolysis, as relevant for thrombolytic therapy.
    Collen D; Lijnen HR
    Thromb Haemost; 1995 Jul; 74(1):167-71. PubMed ID: 8578451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FIBRINOLYTIC THERAPY OF CORONARY THROMBOSIS.
    DEWAR HA
    J Clin Pathol; 1964 May; 17(3):336-7. PubMed ID: 14159476
    [No Abstract]   [Full Text] [Related]  

  • 14. [ROLE OF THE FIBRINOLYTIC ACTIVITY IN THE TREATMENT OF CORONARY THROMBOSIS].
    LABOS I
    Med Glas; 1963; 17():251-2. PubMed ID: 14181694
    [No Abstract]   [Full Text] [Related]  

  • 15. [The optimization of the results with the use of thrombolytic therapy in acute myocardial infarct (I)].
    Cerveró Martí A
    Med Clin (Barc); 1993 May; 100(17):668-74. PubMed ID: 8497174
    [No Abstract]   [Full Text] [Related]  

  • 16. Fibrinolytic therapy of coronary thrombosis. Controlled trial of 75 cases.
    DEWAR HA; STEPHENSON P; HORLER AR; CASSELLS-SMITH AJ; ELLIS PA
    Br Med J; 1963 Apr; 1(5335):915-20. PubMed ID: 14027424
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation of human fibrinolysin (actase); lack of fibrinolytic activity after intravenous administration in man.
    FLETCHER AP; ALKJAERSIG N; SAWYER WD; SHERRY S
    J Am Med Assoc; 1960 Feb; 172():912-5. PubMed ID: 13823474
    [No Abstract]   [Full Text] [Related]  

  • 18. [INCIDENCE AND MORPHOLOGY OF CORONARY THROMBOSIS AND THEIR RELATION TO ANTITHROMBOSIS AND FIBRINOLYTIC TREATMENT].
    SINAPIUS D
    Klin Wochenschr; 1965 Jan; 43():37-43. PubMed ID: 14299770
    [No Abstract]   [Full Text] [Related]  

  • 19. Protective effect of plasmin in marginal donor lungs in an ex vivo lung perfusion model.
    Motoyama H; Chen F; Ohsumi A; Hijiya K; Okita K; Nakajima D; Sakamoto J; Yamada T; Sato M; Aoyama A; Bando T; Date H
    J Heart Lung Transplant; 2013 May; 32(5):505-10. PubMed ID: 23499355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New developments in thrombolytic therapy.
    Collen D; Gold HK
    Adv Exp Med Biol; 1990; 281():333-54. PubMed ID: 2129372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.